Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Preface.

Reeves1, Wilcox

  • 1Bristol, UK, June 2000. Leeds, UK, June 2000.

The Journal of Antimicrobial Chemotherapy
|September 2, 2000
PubMed
Summary
This summary is machine-generated.

The Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) program monitors antimicrobial resistance in severely ill patients. It tracks carbapenem activity, crucial for managing infections caused by resistant bacteria.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Time-frequency mapping of R-R interval during complex partial seizures of temporal lobe origin.

Journal of the autonomic nervous system·2000
Same author

Longitudinal analysis of symptoms reported by patients with chronic fatigue syndrome.

Annals of epidemiology·2000
Same author

Commentary

Fertility and sterility·2000
Same author

Pressure dependence of the irreversibility line in Bi2Sr2CaCu2O(8+delta): role of anisotropy in flux-line formation

Physical review letters·2000
Same author

Preface.

The Journal of antimicrobial chemotherapy·2000
Same author

The public health career of jack C. Smith. Looking beyond the statistics

American journal of preventive medicine·2000

Area of Science:

  • Clinical Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance Surveillance

Background:

  • Global antimicrobial resistance necessitates efficient monitoring programs.
  • The Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) program was established in 1997.
  • MYSTIC focuses on pathogens from severely ill patients, particularly those with resistance to other antibiotics.

Purpose of the Study:

  • To monitor the in vitro activity of carbapenems, specifically meropenem.
  • To assess carbapenem activity in centers where prevalent strains exhibit resistance to other beta-lactams and drug classes.
  • To provide insights into antimicrobial resistance patterns for optimal patient management.

Main Methods:

  • Data collection through the MYSTIC surveillance program.

Related Experiment Videos

  • Analysis of in vitro susceptibility testing data for meropenem.
  • Comparison of resistance patterns across different geographical regions (Americas, Europe, Asia, Middle East).

    • Main Results:

    • Meropenem exhibits potent in vitro activity against many Gram-negative pathogens.
    • The MYSTIC program identifies regional variations in antimicrobial susceptibility patterns.
    • Baseline susceptibility data from the USA, Mexico, and Brazil are presented.

    Conclusions:

    • Long-term antimicrobial resistance surveillance is vital for effective treatment strategies.
    • Standardized data presentation and analysis are crucial for surveillance programs.
    • The MYSTIC program provides valuable data for understanding and combating antimicrobial resistance.